LifeTech Scientific Corporation (HKG:1302)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.470
+0.070 (5.00%)
Jul 31, 2026, 4:08 PM HKT

LifeTech Scientific Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
147.83222.39263.24325.34292.47
Depreciation & Amortization
102.0186.8675.3166.0861.46
Other Amortization
1.091.141.851.030.6
Loss (Gain) From Sale of Assets
3.670.530.060.34-0.06
Asset Writedown & Restructuring Costs
18.6565.97-21.31-
Loss (Gain) From Sale of Investments
12.16-38.45177.9635.2351.08
Loss (Gain) on Equity Investments
-6.20.661.961.770.87
Stock-Based Compensation
223.29133.38112.8462.7219.73
Provision & Write-off of Bad Debts
-0.713.04-0.851.91-8.51
Other Operating Activities
-75.51-120.78-196.46-62.53-91.95
Change in Accounts Receivable
-4.1931.8698.97-18.3456.68
Change in Inventory
81.86-61.28-248.46-112.71-31.36
Change in Accounts Payable
8.33-2.17119.1494.41114.26
Change in Unearned Revenue
9.8113.687.1619.389.78
Change in Other Net Operating Assets
27.2-15.375.34-47.61-33.95
Operating Cash Flow
549.28321.46418.05388.32441.09
Operating Cash Flow Growth
70.87%-23.11%7.66%-11.96%30.30%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-68.47-196.64-200.83-226.37-275.82
Sale of Property, Plant & Equipment
2.020.440.551.880.5
Cash Acquisitions
-3.28-6.77---
Sale (Purchase) of Intangibles
-1.26-8.55-91.86-109.1-67.46
Investment in Securities
-14.86-261.96-190.4-161.17127.65
Other Investing Activities
-41.54-44.0628.6536.3176.14
Investing Cash Flow
-127.38-517.54-453.88-458.47-39

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-99---
Long-Term Debt Issued
----67.5
Total Debt Issued
-99--67.5
Short-Term Debt Repaid
--99---
Long-Term Debt Repaid
-4.52-7.07-9.31-12.47-185.9
Total Debt Repaid
-4.52-106.07-9.31-12.47-185.9
Net Debt Issued (Repaid)
-4.52-7.07-9.31-12.47-118.4
Issuance of Common Stock
8.080.51207.2765.3917.84
Repurchase of Common Stock
-397.13-146.64-26.03-268.29-170.52
Other Financing Activities
23.7936.2410.780.1614.7
Financing Cash Flow
-369.78-116.97182.71-215.2-256.38

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.44-0.52-1.36-0.121.86
Net Cash Flow
53.56-313.56145.52-285.47147.58

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
480.81124.83217.22161.95165.27
Free Cash Flow Growth
285.19%-42.54%34.13%-2.01%-29.21%
Free Cash Flow Margin
35.10%9.57%17.14%14.76%17.86%
Free Cash Flow Per Share
0.110.030.050.040.04
Levered Free Cash Flow
1,02093.63-202.65-68.71165.52
Unlevered Free Cash Flow
1,02094.81-202.2-68.31167.15

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.211.890.720.632.61
Cash Income Tax Paid
93.1678.3580.4171.1159.68
Change in Working Capital
123.02-33.27-17.86-64.87115.41